Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research on breast cancer reported by scientists at University of Frankfurt
February 19th, 2009
"Many prognostic and predictive multigene signatures have been established in breast cancer patients. For treatment decision the assessment of individual prognosis is essential," scientists writing in the journal Geburtshilfe und Frauenheilkunde report. "The choice of specific therapy is basically driven by empirical data although several predictive gene signatures already exist. In this context it would be valuable if specific signatures could be used for estimation of prognosis and prediction of therapy concurrently. Microarray data (Affymetrix HG U133A) of a small samples set of n = 48 breast cancer patients who received an anthracycline-based adjuvant...
Source: Women's Health Weekly (2009-02-19)
|
